Explore By Subject Area   
Return Home
Menu

Lead Editorial

How Memorial Sloan Kettering Cancer Center Scaled EHR-to-EDC Technology

How Memorial Sloan Kettering Cancer Center Scaled EHR-to-EDC Technology

Memorial Sloan Kettering (MSK) Cancer Center’s Senior Director of Clinical Research Informatics and Technology, Joe Lengfellner, tells us how MSK validated and scaled EHR-to-EDC technology across MSK’s vast portfolio of trials.

Read More

Featured Editorial

How Merck Research Labs Is Evolving its Global Clinical Supply to Meet the Demands of Newer Modalities

Read More

Biogen on Digital Innovations to Increase Trial Access and Enhance Patient Experiences

Read More

What Clinical Research Means to Patients in Ukraine, and How Industry Sponsors Can Help

Read More

How CMOs can Leverage AI to Streamline Clinical Development

Read More

How the Roche RNAHub is Advancing Oligonucleotide Development and Delivery

Read More

Editorial by Category

Modernizing Clinical Trial Operations

View All
Expanding Access and Accelerating Cancer Drug Development through Community-Based Oncology Research
Expanding Access and Accelerating Cancer Drug Development through Community-Based Oncology Research
How Sponsors Can Help Sites with Payment, Staffing and Technology
How Sponsors Can Help Sites with Payment, Staffing and Technology
How Site Networks Change Clinical Research Delivery and How Pharma Can Work Better With Them
How Site Networks Change Clinical Research Delivery and How Pharma Can Work Better With Them
From the Archive: 6 Takeaways of DPHARM 2024 Keynote, Tufts’ Kenneth Getz, on Measuring DCT Return on Investment
From the Archive: 6 Takeaways of DPHARM 2024 Keynote, Tufts’ Kenneth Getz, on Measuring DCT Return on Investment

Immuno-Oncology and Cell Therapy

View All
Going After Immune Resistance and Metastases in Cancer Using RNA-Based Therapeutics
Going After Immune Resistance and Metastases in Cancer Using RNA-Based Therapeutics
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
GSK’s Head of Precision Medicine on Biomarker Focus and the Use of Next-Generation Technologies
GSK’s Head of Precision Medicine on Biomarker Focus and the Use of Next-Generation Technologies
T Cell Engagers, Moving Beyond Pembrolizumab, and Medicine Development for Future Patients, with Roche's Ashley Lakner
T Cell Engagers, Moving Beyond Pembrolizumab, and Medicine Development for Future Patients, with Roche's Ashley Lakner

Drug Delivery

View All
Leading Drug Delivery Conference PODD Announces its 15th Annual Agenda
Leading Drug Delivery Conference PODD Announces its 15th Annual Agenda
How Genentech’s Approach to Partnership and Licensing is Driving Innovation
How Genentech’s Approach to Partnership and Licensing is Driving Innovation
PODD Drug Delivery Conference Announces 2025 Keynotes
PODD Drug Delivery Conference Announces 2025 Keynotes
How the Roche RNAHub is Advancing Oligonucleotide Development and Delivery
How the Roche RNAHub is Advancing Oligonucleotide Development and Delivery

Patients as Partners in Clinical Research and Patient Access

View All
Involving Patient Insights in Medicine Development to Better Support Access and Decision-Making: Patients as Partners Europe 2025 Recap
Involving Patient Insights in Medicine Development to Better Support Access and Decision-Making: Patients as Partners Europe 2025 Recap
How Pfizer Is Tackling Patient Insight Continuity Across a Global Organization
How Pfizer Is Tackling Patient Insight Continuity Across a Global Organization
7 Key Takeaways of the Novo Nordisk Rare Disease Survey in Sickle Cell Disease from Patients as Partners 2025
7 Key Takeaways of the Novo Nordisk Rare Disease Survey in Sickle Cell Disease from Patients as Partners 2025
The Role of the Chief Medical Officer In Championing Patient-Centric Drug Development
The Role of the Chief Medical Officer In Championing Patient-Centric Drug Development

Biotech CMO/R&D Leadership

View All
Commercializing Therapies Requires Patient-Centricity and Advocacy
Commercializing Therapies Requires Patient-Centricity and Advocacy
How Investors Evaluate Biotech Companies and CMOs
How Investors Evaluate Biotech Companies and CMOs
One CMO’s Career Journey to Becoming CEO
One CMO’s Career Journey to Becoming CEO
Pediatric Oncology’s Changing Regulatory Landscape and How to Navigate It
Pediatric Oncology’s Changing Regulatory Landscape and How to Navigate It

CRAACO: Clinical Research as a Care Option

View All
Expanding Access and Accelerating Cancer Drug Development through Community-Based Oncology Research
Expanding Access and Accelerating Cancer Drug Development through Community-Based Oncology Research
How Sponsors Can Help Sites with Payment, Staffing and Technology
How Sponsors Can Help Sites with Payment, Staffing and Technology
How Site Networks Change Clinical Research Delivery and How Pharma Can Work Better With Them
How Site Networks Change Clinical Research Delivery and How Pharma Can Work Better With Them
How Memorial Sloan Kettering Cancer Center Scaled EHR-to-EDC Technology
How Memorial Sloan Kettering Cancer Center Scaled EHR-to-EDC Technology

Women Leadership in Biotech

View All
The Conference Forum Sees Record Growth in Attendees Across 2024 Events, Bringing Together Leaders in Medicine Development
The Conference Forum Sees Record Growth in Attendees Across 2024 Events, Bringing Together Leaders in Medicine Development
Women Leadership in Immuno-Oncology: 2022 Celebration Series
Women Leadership in Immuno-Oncology: 2022 Celebration Series
Women Leadership in Immuno-Oncology: 2021 Celebration Series
Women Leadership in Immuno-Oncology: 2021 Celebration Series
Women Leadership in Immuno-Oncology: 2020 Celebration Series
Women Leadership in Immuno-Oncology: 2020 Celebration Series

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.